Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 10.45%

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has an Asset Resilience Ratio of 10.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603707 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.12 Billion

≈ $163.47 Million USD Cash + Short-term Investments

Total Assets

CN¥10.69 Billion

≈ $1.56 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 603707 asset base.

Liquid Assets Composition Over Time

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Nanjing King-friend Biochemical Pharmace balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.12 Billion	10.45%
Total Liquid Assets	CN¥1.12 Billion	10.45%

Asset Resilience Insights

Moderate Liquidity: Nanjing King-friend Biochemical Pharmaceutical Co Ltd has 10.45% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Shenzhen Kangtai Biological Products Co Ltd SHE:300601	Drug Manufacturers - Specialty & Generic	12.99%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	Drug Manufacturers - Specialty & Generic	32.14%

Annual Asset Resilience Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.73%	CN¥1.32 Billion ≈ $192.65 Million	CN¥10.34 Billion ≈ $1.51 Billion	+1.63pp
2024-12-31	11.10%	CN¥1.06 Billion ≈ $154.44 Million	CN¥9.51 Billion ≈ $1.39 Billion	+3.94pp
2023-12-31	7.16%	CN¥681.99 Million ≈ $99.80 Million	CN¥9.52 Billion ≈ $1.39 Billion	+7.15pp
2022-12-31	0.01%	CN¥1.30 Million ≈ $190.23K	CN¥10.01 Billion ≈ $1.46 Billion	-3.15pp
2021-12-31	3.16%	CN¥259.80 Million ≈ $38.02 Million	CN¥8.22 Billion ≈ $1.20 Billion	-7.79pp
2020-12-31	10.96%	CN¥845.79 Million ≈ $123.77 Million	CN¥7.72 Billion ≈ $1.13 Billion	+9.84pp
2019-12-31	1.12%	CN¥56.64 Million ≈ $8.29 Million	CN¥5.08 Billion ≈ $743.13 Million	-18.18pp
2017-12-31	19.30%	CN¥520.00 Million ≈ $76.09 Million	CN¥2.69 Billion ≈ $394.33 Million	+5.42pp
2015-12-31	13.87%	CN¥180.00 Million ≈ $26.34 Million	CN¥1.30 Billion ≈ $189.85 Million	+13.77pp
2014-12-31	0.11%	CN¥1.64 Million ≈ $239.56K	CN¥1.54 Billion ≈ $225.37 Million	--

pp = percentage points

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.82 Billion

CN¥12.44 Billion CNY

Market Cap Rank

#6517 Global

#1307 in China

Share Price

CN¥7.70

Change (1 day)

-2.65%

52-Week Range

CN¥6.84 - CN¥10.47

All Time High

CN¥33.62